⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16774422 | 1.00 | — | — | |
| SCHEMBL333262 | 0.75 | CDK5 (0.32) | — | |
| SCHEMBL29604207 | 0.75 | CDK5 (0.32) | — | |
| SCHEMBL6284974 | 0.69 | SHBG (0.43) | — | |
| SCHEMBL3890863 | 0.66 | — | — | |
| SCHEMBL3890861 | 0.66 | — | — | |
| SCHEMBL12166596 | 0.65 | APLNR (0.32) | — | |
| SCHEMBL12166591 | 0.64 | — | — | |
| SCHEMBL6757996 | 0.64 | — | — | |
| SCHEMBL6757985 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024144724-A1 | A TOPICAL PREPARATE BASED ON ORIGANUM MAJORANA L. ESSENTIAL OIL WITH PROLIFERATIVE AND ANTIMICROBIAL EFFECTS IN WOUND TREATMENT | ATATÜRK ÜNİVERSİTESİ REKTÖRLÜĞÜ BİLİMSEL ARAŞTIRMA PROJELERİ ( BAP ) KOORDİNASYON BİRİMİ (TR) | 2024-07-04 | — | — | WO | disclosed |
| WO-2023057401-A1 | METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS | MERCK PATENT GMBH (DE) | 2023-04-13 | — | — | WO | disclosed |
| US-20220242809-A1 | METHODS FOR ISOLATING ESSENTIAL OILS, PHYTOCHEMICALS AND PHARMACEUTICALLY ACTIVE COMPONENTS FROM BIOMASS AND RECONSTITUTING SYNTHETIC FORMULATIONS COMPRISING SAME | ATLAS HEMP COMPANY LLC (US) | 2022-08-04 | — | — | US | disclosed |
| WO-2022123313-A1 | SKIN SANITIZING COMPOSITIONS CONTAINING MANUKA OIL | Manuka Therapeutics Ltd. (NZ) | 2022-06-16 | — | — | WO | disclosed |